Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Esophageal Neoplasms × Dexmedetomidine × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1 Gastrointestinal 1

Conditions

Pain, Postoperative 19 Breast Neoplasms 13 Brain Neoplasms 11 Agnosia 7 Neoplasms 6 Lung Neoplasms 5 Delirium 5 Thyroid Neoplasms 4 Stomach Neoplasms 4 Pituitary Neoplasms 3 Pain 3 Inflammation 3 Emergence Delirium 3 Colorectal Neoplasms 3 Chronic Pain 3 Urinary Bladder Neoplasms 2 Supratentorial Neoplasms 2 Rectal Neoplasms 2 Prostatic Neoplasms 2 Pheochromocytoma 2 Pain, Intractable 2 Neoplasm Metastasis 2 Liver Neoplasms 2 Dexmedetomidine 2 Colonic Neoplasms 2 Central Nervous System Diseases 2 Abdominal Neoplasms 2 Thrombosis 1 Spinal Cord Neoplasms 1 Sleep Initiation and Maintenance Disorders 1

Interventions

Cisplatin 161 Fluorouracil 134 Paclitaxel 127 Radiotherapy 125 Oxaliplatin 87 Docetaxel 71 Carboplatin 71 Irinotecan 60 pembrolizumab 58 Capecitabine 57 Leucovorin 56 Radiation 48 Esophagectomy 44 Surgical Procedures, Operative 41 Drug Therapy 38 Neoadjuvant Therapy 28 Cetuximab 25 Nivolumab 24 Bevacizumab 21 camrelizumab 20 Trastuzumab 20 S 1 (combination) 19 Chemoradiotherapy 19 Magnetic Resonance Spectroscopy 18 Epirubicin 16 Albumin-Bound Paclitaxel 16 Blood Specimen Collection 15 tislelizumab 14 Taxes 14 Radiotherapy, Intensity-Modulated 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00839605 2016-10-04

Dex-One-Lung

University of Missouri-Columbia

GastrointestinalThoracic

Esophageal Neoplasms, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡